Ligand Pharmaceuticals traded at $90.58 this Friday July 1st, increasing $1.36 or 1.52 percent since the previous trading session. Looking back, over the last four weeks, Ligand Pharmaceuticals gained 5.08 percent. Over the last 12 months, its price fell by 32.02 percent. Looking ahead, we forecast Ligand Pharmaceuticals to be priced at 88.13 by the end of this quarter and at 81.15 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
90.58
Daily Change
1.52%
Yearly
-32.02%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acorda Therapeutics 0.48 0.01 3.20% -89.34%
Agenus 1.96 0.02 1.03% -64.49%
Amgen 245.55 2.25 0.92% -1.27%
Anika Therapeutics 22.51 0.19 0.85% -49.04%
Arrowhead Research 35.96 0.75 2.13% -43.04%
Baxter International 65.49 1.26 1.96% -19.90%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Clovis Oncology 2.85 1.05 58.33% -49.91%
Endo International 0.57 0.10 22.42% -86.74%
Enanta Pharmaceuticals 49.63 2.36 4.99% 12.29%
Gilead Sciences 62.36 0.55 0.89% -10.01%
GlaxoSmithKline 1,785.60 20.00 1.13% 24.19%
Glaxosmithkline 43.75 0.22 0.51% 8.27%
Heron Therapeutics 2.72 -0.07 -2.51% -81.71%
Harsco 7.24 0.13 1.83% -65.88%
Immunogen 4.61 0.11 2.44% -28.30%
Insmed 20.89 1.17 5.93% -26.70%
Ionis Pharmaceuticals 38.06 1.04 2.81% -4.66%
Karyopharm Therapeutics 4.73 0.22 4.88% -55.00%
Lannett 0.56 -0.02 -3.46% -87.85%
Ligand Pharmaceuticals 90.58 1.36 1.52% -32.02%
Eli Lilly 324.71 0.48 0.15% 38.79%
MacroGenics 3.05 0.10 3.39% -89.37%
Merck & Co 92.42 1.25 1.37% 17.58%
Pacira 57.85 -0.45 -0.77% -2.41%
Pfizer 52.31 -0.12 -0.23% 31.66%
Rigel Pharmaceuticals 1.25 0.12 10.62% -71.66%
Sangamo BioSciences 4.28 0.14 3.38% -63.45%
Spectrum Pharmaceuticals 0.77 -0.01 -1.33% -78.86%
Teva Pharmaceutical Industries 7.89 0.37 4.92% -19.74%
Veracyte 21.10 1.20 6.03% -46.58%
Intrexon 1.41 0.07 5.22% -78.04%

Indexes Price Day Year
USND 11128 99.11 0.90% -23.99%
US400 2296 26.97 1.19% -15.27%

Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company. The Company is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's technology includes Captisol Technology, OmniAb Technologies (OMT), Icagen Ion Channel Technology Platform, Pelican Expression Technology platform and Liver Targeting Prodrug (LTP) Technology to assist companies in their work toward securing prescription drug and biologic approvals. It has partnerships and license agreements with over 130 pharmaceutical and biotechnology companies and over 300 programs that are in various stages of commercialization, development or research and are fully funded by its collaboration partners and licensees. Its partners and licensees have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.